These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 26648321)

  • 21. Sarcopenia Evaluated Using the Skeletal Muscle Index Is a Significant Prognostic Factor for Metastatic Urothelial Carcinoma.
    Taguchi S; Akamatsu N; Nakagawa T; Gonoi W; Kanatani A; Miyazaki H; Fujimura T; Fukuhara H; Kume H; Homma Y
    Clin Genitourin Cancer; 2016 Jun; 14(3):237-43. PubMed ID: 26337653
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The consistency of skeletal muscle mass measured by CT at L
    Yang M; Hou SM; Yuan L; Wang M; Zheng J; Lu KQ; Yan Y; Zhang SY; Li M; Cao JY; Yang M; Zhang XL; Liu H; Liu BC; Wang Y; Wang B
    Zhonghua Yi Xue Za Zhi; 2023 Sep; 103(36):2850-2858. PubMed ID: 37726991
    [No Abstract]   [Full Text] [Related]  

  • 23. Skeletal Muscle Loss Is an Imaging Biomarker of Outcome after Definitive Chemoradiotherapy for Locally Advanced Cervical Cancer.
    Lee J; Chang CL; Lin JB; Wu MH; Sun FJ; Jan YT; Hsu SM; Chen YJ
    Clin Cancer Res; 2018 Oct; 24(20):5028-5036. PubMed ID: 29959140
    [No Abstract]   [Full Text] [Related]  

  • 24. Thigh muscle by CT images as a predictor of mortality in patients with newly diagnosed colorectal cancer.
    Ferreira GMC; da Costa Pereira JP; Miranda AL; de Medeiros GOC; Bennemann NA; Alves VA; Costa EC; Verde SMML; Chaves GV; Murad LB; Gonzalez MC; Prado CM; Fayh APT
    Sci Rep; 2024 Jul; 14(1):17267. PubMed ID: 39068231
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic Role of Conversion Surgery for Unresectable Gastric Cancer.
    Fukuchi M; Ishiguro T; Ogata K; Suzuki O; Kumagai Y; Ishibashi K; Ishida H; Kuwano H; Mochiki E
    Ann Surg Oncol; 2015 Oct; 22(11):3618-24. PubMed ID: 25663597
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Computed tomography-determined skeletal muscle density predicts 3-year mortality in initial-dialysis patients in China.
    Sheng MJ; Cao JY; Hou SM; Li M; Wang Y; Fang Q; Miao AF; Yang M; Liu SS; Hu CH; Liu CL; Wang SY; Zheng J; Xiao JJ; Zhang XL; Liu H; Liu BC; Wang B
    J Cachexia Sarcopenia Muscle; 2023 Dec; 14(6):2569-2578. PubMed ID: 37722854
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic value of computed tomography‑derived skeletal muscle index and radiodensity in patients with gastric cancer after curative gastrectomy.
    Hashimoto I; Komori K; Maezawa Y; Nagasawa S; Kawabe T; Aoyama T; Hayashi T; Yamada T; Sato T; Ogata T; Cho H; Yoshikawa T; Yukawa N; Rino Y; Saito A; Oshima T
    Oncol Lett; 2024 Oct; 28(4):458. PubMed ID: 39114573
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Capecitabine and cisplatin with or without cetuximab for patients with previously untreated advanced gastric cancer (EXPAND): a randomised, open-label phase 3 trial.
    Lordick F; Kang YK; Chung HC; Salman P; Oh SC; Bodoky G; Kurteva G; Volovat C; Moiseyenko VM; Gorbunova V; Park JO; Sawaki A; Celik I; Götte H; Melezínková H; Moehler M;
    Lancet Oncol; 2013 May; 14(6):490-9. PubMed ID: 23594786
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of skeletal muscle mass in patients with recurrent gastric cancer.
    Matsunaga T; Satio H; Miyauchi W; Shishido Y; Miyatani K; Murakami Y; Hanaki T; Kihara K; Yamamoto M; Tokuyasu N; Takano S; Sakamoto T; Hasegawa T; Fujiwara Y
    World J Surg Oncol; 2021 Jun; 19(1):170. PubMed ID: 34116681
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Muscle radiodensity loss during cancer therapy is predictive for poor survival in advanced endometrial cancer.
    Lee J; Lin JB; Wu MH; Jan YT; Chang CL; Huang CY; Sun FJ; Chen YJ
    J Cachexia Sarcopenia Muscle; 2019 Aug; 10(4):814-826. PubMed ID: 31094101
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A comparison of CT based measures of skeletal muscle mass and density from the Th4 and L3 levels in patients with advanced non-small-cell lung cancer.
    Grønberg BH; Sjøblom B; Wentzel-Larsen T; Baracos VE; Hjermstad MJ; Aass N; Bremnes RM; Fløtten Ø; Bye A; Jordhøy M
    Eur J Clin Nutr; 2019 Jul; 73(7):1069-1076. PubMed ID: 30254241
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The relationship between the mode of presentation, CT-derived body composition, systemic inflammatory grade and survival in colon cancer.
    Golder AM; Sin LKE; Alani F; Alasadi A; Dolan R; Mansouri D; Horgan PG; McMillan DC; Roxburgh CS
    J Cachexia Sarcopenia Muscle; 2022 Dec; 13(6):2863-2874. PubMed ID: 36218135
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of low skeletal muscle mass and quality on clinical outcomes in patients with head and neck cancer undergoing (chemo)radiation.
    Bardoscia L; Besutti G; Pellegrini M; Pagano M; Bonelli C; Bonelli E; Braglia L; Cozzi S; Roncali M; Iotti C; Pinto C; Pattacini P; Ciammella P
    Front Nutr; 2022; 9():994499. PubMed ID: 36466387
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Associations between muscle measures, survival, and toxicity in patients with limited stage small cell lung cancer.
    Halvorsen TO; Valan CD; Slaaen M; Grønberg BH
    J Cachexia Sarcopenia Muscle; 2020 Oct; 11(5):1283-1290. PubMed ID: 32725772
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Skeletal muscle gauge as a prognostic factor in patients with colorectal cancer.
    Park IK; Yang SS; Chung E; Cho ES; Lee HS; Shin SJ; Im YC; Park EJ; Baik SH; Lee KY; Kang J
    Cancer Med; 2021 Dec; 10(23):8451-8461. PubMed ID: 34643052
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic significance of the skeletal muscle index and an inflammation biomarker in patients with breast cancer who underwent postoperative adjuvant radiotherapy.
    Hua X; Deng JP; Long ZQ; Zhang WW; Huang X; Wen W; Guo L; He ZY; Lin HX
    Curr Probl Cancer; 2020 Apr; 44(2):100513. PubMed ID: 31732239
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Body composition parameters predict pathological response and outcomes in locally advanced gastric cancer after neoadjuvant treatment: A multicenter, international study.
    Lin JX; Tang YH; Zhou WX; Desiderio J; Parisi A; Xie JW; Wang JB; Cianchi F; Antonuzzo L; Borghi F; Lu J; Chen QY; Cao LL; Lin M; Tu RH; Staderini F; Marano A; Peluso C; Li P; Zheng CH; Ma YB; Huang CM
    Clin Nutr; 2021 Aug; 40(8):4980-4987. PubMed ID: 34364237
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of muscle mass loss on outcomes in advanced or metastatic gastric cancer patients receiving a second-line treatment.
    Zurlo V; Rosa F; Rinninella E; Pontolillo L; Beccia V; Maratta M; Tortora G; Alfieri S; Pozzo C; Strippoli A
    Eur Rev Med Pharmacol Sci; 2024 Feb; 28(4):1575-1584. PubMed ID: 38436190
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Skeletal Muscle Quality Beyond Average Muscle Attenuation: A Proposal of Skeletal Muscle Phenotypes to Predict Short-Term Survival in Patients With Endometrial Cancer.
    Rodrigues CS; Chaves GV
    J Natl Compr Canc Netw; 2018 Feb; 16(2):153-160. PubMed ID: 29439176
    [No Abstract]   [Full Text] [Related]  

  • 40. Treatment of stage IV gastric cancer with induction chemotherapy using S-1 and cisplatin followed by curative resection in selected patients.
    Saito M; Kiyozaki H; Takata O; Suzuki K; Rikiyama T
    World J Surg Oncol; 2014 Dec; 12():406. PubMed ID: 25551581
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.